Organon (OGN) EBITDA Margin (2020 - 2026)
Organon (OGN) posted quarterly EBITDA Margin of 20.73% for Q2 2026, up 41.0% year-over-year from 14.7% in Q2 2025, and up 28.8% on a QoQ basis from 16.1% in Q1 2026.
Organon (OGN) EBITDA Margin (2020 - 2026) Analysis & Trends
Organon has reported EBITDA Margin for 7 years, with the latest figure at 20.73% in Q2 2026.
- EBITDA Margin for Q2 2026 came in at 20.73%, up 41.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 18.38% (down 171.0% YoY), and the FY2025 annual result was 18.19%, down 453.0% from the prior year.
- EBITDA Margin grew to 20.73% in Q2 2026, from 16.1% in the prior quarter.
- Over five years, EBITDA Margin peaked at 25.98% in Q3 2024 and troughed at 36.23% in Q4 2023.
- A 5-year average of 2.41% and a median of 3.17% in 2022 frame the typical range for EBITDA Margin.
- The widest annual swing landed in 2023, when EBITDA Margin slumped 1752 bps; it then soared 6100 bps in 2024.
- A 5-year view of EBITDA Margin shows it stood at 32.53% in 2022, then slipped by 11 bps to 36.23% in 2023, then jumped by 150 bps to 18.09% in 2024, then dropped by 23 bps to 13.93% in 2025, then soared by 49 bps to 20.73% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 20.73% in Q2 2026, 16.1% in Q1 2026, and 13.93% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 28.37% |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 5.72% |
| 10 | Organon | 3.61 Bn | 2.47 Bn | 847.00 Mn | 20.73% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.73% |
| Mar 31, 2026 | 16.10% |
| Dec 31, 2025 | 13.93% |
| Sep 30, 2025 | 22.35% |
| Jun 30, 2025 | 20.33% |
| Mar 31, 2025 | 15.80% |
| Dec 31, 2024 | 18.09% |
| Sep 30, 2024 | 25.98% |
| Jun 30, 2024 | 24.02% |
| Mar 31, 2024 | -26.45% |
| Dec 31, 2023 | -36.23% |
| Sep 30, 2023 | -35.02% |
| Jun 30, 2023 | -24.00% |
| Mar 31, 2023 | -22.43% |
| Dec 31, 2022 | -32.53% |
| Sep 30, 2022 | -17.50% |
| Jun 30, 2022 | -18.99% |
| Mar 31, 2022 | -7.59% |
| Dec 31, 2021 | -22.65% |
| Sep 30, 2021 | -13.75% |